Fernández A, González Astorga B, Rodríguez N, Safont MJ, Castro Albarran P, Mareque M, Oyagüez I
A cost analysis of adverse event management of systemic therapies for metastatic colorectal cancer on patients with at least two previous lines of treatment in Spain
Clinicoecon Outcomes Res. 2026;18:586388. doi: 10.2147/CEOR.S586388
Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
ClinicoEconomics and Outcomes Research. 2023:15 659–671
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with CD-33 positive acute myeloid leukaemia in Spain
ClinicoEconomics and Outcomes Research 2021; 13:263-277
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G